ArticleJAAD case reports2025
Nemolizumab for the treatment of refractory primary localized cutaneous amyloidosis in a nonatopic patient.
Gabriela Soto-Canetti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it